Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pLenti CMV TRE3G BCL2L11 G156E Neo
(Plasmid #140748)


Item Catalog # Description Quantity Price (USD)
Plasmid 140748 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


  • Vector backbone
    pLenti CMVTRE3G eGFP Neo (w821-1)
  • Backbone manufacturer
  • Backbone size w/o insert (bp) 8804
  • Total vector size (bp) 8509
  • Vector type
    Mammalian Expression, Lentiviral
  • Selectable markers
    Neomycin (select with G418)

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
    NEB Stable
  • Copy number


  • Gene/Insert name
  • Alt name
  • Species
    H. sapiens (human)
  • Insert Size (bp)
  • Mutation
    Changed Glycine 156 to Glutamate
  • GenBank ID
  • Entrez Gene
    BCL2L11 (a.k.a. BAM, BIM, BOD)
  • Promoter CMV TRE3G

Cloning Information

Resource Information

Terms and Licenses

  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pLenti CMV TRE3G BCL2L11 G156E Neo was a gift from Scott Dixon (Addgene plasmid # 140748 ; ; RRID:Addgene_140748)
  • For your References section:

    Kinetic Heterogeneity of Cancer Cell Fractional Killing. Inde Z, Forcina GC, Denton K, Dixon SJ. Cell Rep. 2020 Jul 7;32(1):107845. doi: 10.1016/j.celrep.2020.107845. 10.1016/j.celrep.2020.107845 PubMed 32640215